These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25051426)

  • 21. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease.
    Waxman EA; Lynch DR
    Neuroscientist; 2005 Feb; 11(1):37-49. PubMed ID: 15632277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Architecture and function of NMDA receptors: an evolutionary perspective.
    Stroebel D; Paoletti P
    J Physiol; 2021 May; 599(10):2615-2638. PubMed ID: 32786006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer's disease.
    Bordji K; Becerril-Ortega J; Buisson A
    Rev Neurosci; 2011; 22(3):285-94. PubMed ID: 21568789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMDA receptor subunits: function and pharmacology.
    Paoletti P; Neyton J
    Curr Opin Pharmacol; 2007 Feb; 7(1):39-47. PubMed ID: 17088105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into the Crosstalk between NMDARs and Iron: Implications for Understanding Pathology of Neurological Diseases.
    Xu H; Jiang H; Xie J
    Front Mol Neurosci; 2017; 10():71. PubMed ID: 28360837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of glutamate and excitotoxicity in neurologic diseases].
    Hugon J; Vallat JM; Dumas M
    Rev Neurol (Paris); 1996 Apr; 152(4):239-48. PubMed ID: 8763652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.
    Hynd MR; Scott HL; Dodd PR
    Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMDA receptors in clinical neurology: excitatory times ahead.
    Kalia LV; Kalia SK; Salter MW
    Lancet Neurol; 2008 Aug; 7(8):742-55. PubMed ID: 18635022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors.
    Léveillé F; El Gaamouch F; Gouix E; Lecocq M; Lobner D; Nicole O; Buisson A
    FASEB J; 2008 Dec; 22(12):4258-71. PubMed ID: 18711223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?
    Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):826-32. PubMed ID: 14619404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New targets for pharmacological intervention in the glutamatergic synapse.
    Gardoni F; Di Luca M
    Eur J Pharmacol; 2006 Sep; 545(1):2-10. PubMed ID: 16831414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors.
    Zhang X; Chergui K
    Neuropharmacology; 2015 May; 92():108-15. PubMed ID: 25619731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrasynaptic NMDA receptor involvement in central nervous system disorders.
    Parsons MP; Raymond LA
    Neuron; 2014 Apr; 82(2):279-93. PubMed ID: 24742457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
    Soni N; Reddy BV; Kumar P
    Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases.
    Seillier C; Lesept F; Toutirais O; Potzeha F; Blanc M; Vivien D
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.
    Fan MM; Raymond LA
    Prog Neurobiol; 2007 Apr; 81(5-6):272-93. PubMed ID: 17188796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruiting extrasynaptic NMDA receptors augments synaptic signaling.
    Harris AZ; Pettit DL
    J Neurophysiol; 2008 Feb; 99(2):524-33. PubMed ID: 18057106
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.